Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages

Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) have been assigned a consensus recommendation of "Hold" from the eleven research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $10.28.

A number of research firms have recently weighed in on MRVI. William Blair reiterated a "market perform" rating on shares of Maravai LifeSciences in a research report on Friday, November 8th. Wolfe Research assumed coverage on shares of Maravai LifeSciences in a research report on Thursday, November 14th. They set a "peer perform" rating for the company. Royal Bank of Canada dropped their target price on shares of Maravai LifeSciences from $17.00 to $13.00 and set an "outperform" rating for the company in a research report on Friday, November 8th. Guggenheim began coverage on shares of Maravai LifeSciences in a research report on Thursday, December 19th. They set a "neutral" rating for the company. Finally, The Goldman Sachs Group downgraded Maravai LifeSciences from a "neutral" rating to a "sell" rating and reduced their target price for the company from $7.00 to $4.25 in a report on Thursday, December 5th.

Insider Activity

In related news, insider Carl Hull acquired 175,000 shares of the business's stock in a transaction that occurred on Monday, November 11th. The shares were bought at an average cost of $5.64 per share, with a total value of $987,000.00. Following the completion of the purchase, the insider now directly owns 175,000 shares in the company, valued at $987,000. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.63% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Maravai LifeSciences during the second quarter worth $32,000. Venturi Wealth Management LLC bought a new stake in Maravai LifeSciences during the third quarter valued at $47,000. Custom Index Systems LLC acquired a new stake in Maravai LifeSciences during the 3rd quarter worth about $97,000. Y Intercept Hong Kong Ltd bought a new position in shares of Maravai LifeSciences in the 3rd quarter worth about $105,000. Finally, Headlands Technologies LLC lifted its stake in shares of Maravai LifeSciences by 205.9% in the 2nd quarter. Headlands Technologies LLC now owns 14,935 shares of the company's stock valued at $107,000 after purchasing an additional 10,053 shares during the period. Institutional investors own 50.25% of the company's stock.

Maravai LifeSciences Price Performance

Shares of MRVI stock traded down $1.28 during trading on Friday, hitting $4.85. The company had a trading volume of 6,564,286 shares, compared to its average volume of 2,241,498. The firm has a market capitalization of $1.22 billion, a P/E ratio of -2.96 and a beta of -0.07. Maravai LifeSciences has a one year low of $4.28 and a one year high of $11.56. The company has a debt-to-equity ratio of 0.89, a quick ratio of 9.94 and a current ratio of 10.74. The stock's 50-day moving average price is $5.65 and its 200 day moving average price is $7.41.

About Maravai LifeSciences

Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.